HCA Holdings, Inc. (NYSE:HCA)‘s stock had its “market perform” rating reissued by equities researchers at William Blair in a research note issued to investors on Tuesday, November 21st.

Other research analysts have also issued research reports about the company. KeyCorp restated a “buy” rating and issued a $95.00 target price on shares of HCA in a report on Thursday, September 7th. Cantor Fitzgerald restated a “buy” rating and issued a $95.00 target price on shares of HCA in a report on Wednesday, September 6th. Argus dropped their target price on HCA from $100.00 to $93.00 and set a “buy” rating on the stock in a report on Monday, August 14th. Robert W. Baird restated a “buy” rating on shares of HCA in a report on Thursday, September 28th. Finally, ValuEngine upgraded HCA from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and seventeen have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $90.20.

HCA (NYSE:HCA) opened at $77.35 on Tuesday. HCA has a fifty-two week low of $69.59 and a fifty-two week high of $91.03. The company has a quick ratio of 1.41, a current ratio of 1.68 and a debt-to-equity ratio of -6.46. The stock has a market capitalization of $27,329.31, a P/E ratio of 11.71, a price-to-earnings-growth ratio of 1.14 and a beta of 0.50.

HCA (NYSE:HCA) last posted its earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $1.21. HCA had a negative return on equity of 47.16% and a net margin of 6.13%. The company had revenue of $10.70 billion for the quarter, compared to analyst estimates of $10.70 billion. During the same quarter last year, the company earned $1.45 earnings per share. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. equities analysts expect that HCA will post 6.55 EPS for the current year.

In related news, SVP Victor L. Campbell sold 8,000 shares of the stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $75.82, for a total transaction of $606,560.00. Following the completion of the sale, the senior vice president now directly owns 127,275 shares of the company’s stock, valued at $9,649,990.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Michael S. Cuffe sold 2,150 shares of the firm’s stock in a transaction on Tuesday, October 17th. The stock was sold at an average price of $78.00, for a total value of $167,700.00. Following the completion of the sale, the insider now directly owns 12,476 shares of the company’s stock, valued at $973,128. The disclosure for this sale can be found here. Insiders have sold 22,450 shares of company stock valued at $1,737,681 over the last ninety days. 2.90% of the stock is currently owned by company insiders.

A number of large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its position in HCA by 0.7% in the second quarter. Vanguard Group Inc. now owns 19,718,250 shares of the company’s stock worth $1,719,431,000 after buying an additional 141,258 shares during the last quarter. Glenview Capital Management LLC increased its position in HCA by 2.6% in the second quarter. Glenview Capital Management LLC now owns 14,899,289 shares of the company’s stock worth $1,299,218,000 after buying an additional 384,024 shares during the last quarter. Longview Partners Guernsey LTD increased its position in HCA by 22.6% in the third quarter. Longview Partners Guernsey LTD now owns 11,135,155 shares of the company’s stock worth $886,247,000 after buying an additional 2,053,701 shares during the last quarter. LSV Asset Management increased its position in HCA by 5.5% in the second quarter. LSV Asset Management now owns 3,907,939 shares of the company’s stock worth $340,772,000 after buying an additional 203,290 shares during the last quarter. Finally, APG Asset Management N.V. increased its position in HCA by 141.4% in the third quarter. APG Asset Management N.V. now owns 3,423,381 shares of the company’s stock worth $272,467,000 after buying an additional 2,005,193 shares during the last quarter. 75.35% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: This piece was posted by American Banking News and is owned by of American Banking News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of international trademark and copyright law. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/11/21/william-blair-initiates-coverage-on-hca-holdings-inc-hca.html.

HCA Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.